TY - JOUR
KW - buprenorphine
KW - Medications for opioid use disorder
KW - Opiate Substitution Treatment
KW - opioid-related disorders
KW - polypharmacy
KW - Primary Health Care
AU - C. X. Du
AU - J. Shi
AU - J. M. Tetrault
AU - L. M. Madden
AU - D. T. Barry
A1 - 
AB - BACKGROUND: Office-based opioid treatment (OBOT) is an evidence-based treatment model for opioid use disorder (OUD) offered by both addiction and general primary care providers (PCPs). Calls exist for more PCPs to offer OBOT. Few studies have been conducted on the primary care characteristics of OBOT patients. OBJECTIVE: To characterize medical conditions, medications, and treatment outcomes among patients receiving OBOT with buprenorphine for OUD, and to describe differences among patients by age and by time in care. METHODS: This study is a retrospective review of medical records on or before 4/29/2019 at an outpatient primary care clinic within a nonprofit addiction treatment setting. Inclusion criterion was all clinic patients actively enrolled in the OBOT program. Patients not prescribed buprenorphine or with no OBOT visits were excluded. RESULTS: Of 355 patients, 42.0% had another PCP. Common comorbid conditions included chronic pain and psychiatric diagnosis. Few patients had chronic viral hepatitis or HIV. Patients reported a median of 4 medications. Common medications were cardiovascular, antidepressant, and nonopioid pain agents. Older patients had a higher median number of medications. There was no significant difference in positive opioid urine toxicology (UT) based on age, chronic pain status, or psychoactive medications. Patients retained >1 year were less likely to have positive opioid UT. CONCLUSION: Clinical needs of many patients receiving OBOT are similar to those of the general population, supporting calls for PCPs to provide OBOT.
AD - Yale University School of Medicine, New Haven, CT, United States.; Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States.; The APT Foundation Inc., New Haven, CT, United States.; Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States.; The APT Foundation Inc., New Haven, CT, United States.; Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States.; The APT Foundation Inc., New Haven, CT, United States.; The APT Foundation Inc., New Haven, CT, United States.; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.
BT - Family practice
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
CP - 2
DO - 10.1093/fampra/cmab166
IS - 2
JF - Family practice
LA - eng
M1 - Journal Article
N2 - BACKGROUND: Office-based opioid treatment (OBOT) is an evidence-based treatment model for opioid use disorder (OUD) offered by both addiction and general primary care providers (PCPs). Calls exist for more PCPs to offer OBOT. Few studies have been conducted on the primary care characteristics of OBOT patients. OBJECTIVE: To characterize medical conditions, medications, and treatment outcomes among patients receiving OBOT with buprenorphine for OUD, and to describe differences among patients by age and by time in care. METHODS: This study is a retrospective review of medical records on or before 4/29/2019 at an outpatient primary care clinic within a nonprofit addiction treatment setting. Inclusion criterion was all clinic patients actively enrolled in the OBOT program. Patients not prescribed buprenorphine or with no OBOT visits were excluded. RESULTS: Of 355 patients, 42.0% had another PCP. Common comorbid conditions included chronic pain and psychiatric diagnosis. Few patients had chronic viral hepatitis or HIV. Patients reported a median of 4 medications. Common medications were cardiovascular, antidepressant, and nonopioid pain agents. Older patients had a higher median number of medications. There was no significant difference in positive opioid urine toxicology (UT) based on age, chronic pain status, or psychoactive medications. Patients retained >1 year were less likely to have positive opioid UT. CONCLUSION: Clinical needs of many patients receiving OBOT are similar to those of the general population, supporting calls for PCPs to provide OBOT.
PY - 2022
SN - 1460-2229; 0263-2136; 0263-2136
SP - 234
EP - 240
EP - 
T1 - Primary care and medication management characteristics among patients receiving office-based opioid treatment with buprenorphine
T2 - Family practice
TI - Primary care and medication management characteristics among patients receiving office-based opioid treatment with buprenorphine
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U2 - 34893825
U3 - 10.1093/fampra/cmab166
VL - 39
VO - 1460-2229; 0263-2136; 0263-2136
Y1 - 2022
Y2 - Mar 24
ER -